• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Phenotypic difference by the combination of both oncogenes and tumor suppressors in melanoma

Research Project

Project/Area Number 18K07227
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 50010:Tumor biology-related
Research InstitutionUniversity of Toyama

Principal Investigator

Yokoyama Satoru  富山大学, 学術研究部薬学・和漢系, 准教授 (90613498)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywordsがん遺伝子 / がん抑制遺伝子 / 悪性黒色腫 / 細胞運動 / PTEN / 腫瘍微小環境
Outline of Final Research Achievements

In this project, we focused on the difference of oncogenes and tumor suppressors even in similar melanoma derived from cutaneous and uveal tissue.
To this end, we established the melanocytes overexpressing BRAF or GNA11, which is related to cutaneous melanoma or uveal melanoma, respectively. In addition, PTEN was knocked out in each established cells.
We determined the increased tumor growth and cell migratory ability only in BRAF/PTEN-loss cells though the detailed mechanism is unknown.

Academic Significance and Societal Importance of the Research Achievements

死因の第一位が悪性新生物であり、今回の研究課題が腫瘍の発生の根幹に迫る研究内容であることから、学術的意義や社会的意義は十分あると考えられる。
現在詳細についての検討中であり、興味深い結果が期待される。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (38 results)

All 2020 2019 2018 Other

All Int'l Joint Research (3 results) Journal Article (8 results) (of which Int'l Joint Research: 4 results,  Peer Reviewed: 8 results,  Open Access: 5 results) Presentation (25 results) (of which Int'l Joint Research: 1 results) Remarks (2 results)

  • [Int'l Joint Research] Massachusetts General Hospital(米国)

    • Related Report
      2020 Annual Research Report
  • [Int'l Joint Research] Massachusetts General Hospital(米国)

    • Related Report
      2019 Research-status Report
  • [Int'l Joint Research] NNEA of Indonesia(インドネシア)

    • Related Report
      2019 Research-status Report
  • [Journal Article] Anti-metastatic Effects of Baicalein by Targeting STAT3 Activity in Breast Cancer Cells2020

    • Author(s)
      Susmitha Gorrepotu D, Miyazato K, Ogura K, Yokoyama S, Hayakawa Y.
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 43 Issue: 12 Pages: 1899-1905

    • DOI

      10.1248/bpb.b20-00571

    • NAID

      130007948716

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2020-12-01
    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization2020

    • Author(s)
      Yokoyama Satoru、Iwakami Yusuke、Hang Zhao、Kin Ryoei、Zhou Yue、Yasuta Yutaka、Takahashi Atsushi、Hayakawa Yoshihiro、Sakurai Hiroaki
    • Journal Title

      Scientific Reports

      Volume: 10 Issue: 1 Pages: 19214-19214

    • DOI

      10.1038/s41598-020-76373-y

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anti‑inflammatory compounds moracin O and P from Morus alba Linn. (Sohakuhi) target the NF‑κB pathway.2020

    • Author(s)
      Hardianti B, Umeyama L, Li F, Yokoyama S, Hayakawa Y.
    • Journal Title

      Mol Med Rep.

      Volume: 22 Issue: 6 Pages: 5385-5391

    • DOI

      10.3892/mmr.2020.11615

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] ERK?mediated negative feedback regulation of oncogenic EGFRvIII in glioblastoma cells2020

    • Author(s)
      Haryuni Ratna、Tanaka Tomohiro、Zhou Yue、Yokoyama Satoru、Sakurai Hiroaki
    • Journal Title

      Oncology Letters

      Volume: 20 Issue: 3 Pages: 2477-2482

    • DOI

      10.3892/ol.2020.11760

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death2019

    • Author(s)
      Xu Xiaoou、Eshima Shizuka、Kato Shinichiro、Fisher David E.、Sakurai Hiroaki、Hayakawa Yoshihiro、Yokoyama Satoru
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 19 Issue: 2 Pages: 627-636

    • DOI

      10.1158/1535-7163.mct-19-0451

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Negative feedback regulation of ErbB4 tyrosine kinase activity by ERK-mediated non-canonical phosphorylation2019

    • Author(s)
      Haryuni Ratna Dini、Watabe Satoko、Yamaguchi Asako、Fukushi Yayoi、Tanaka Tomohiro、Kawasaki Yuki、Zhou Yue、Yokoyama Satoru、Sakurai Hiroaki
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 514 Issue: 2 Pages: 456-461

    • DOI

      10.1016/j.bbrc.2019.04.125

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] STAM-binding protein regulates melanoma metastasis through SLUG stabilization.2018

    • Author(s)
      Iwakami Y, Yokoyama S, Watanabe K, Hayakawa Y.
    • Journal Title

      Biochem Biophys Res Commun.

      Volume: 507 Issue: 1-4 Pages: 484-488

    • DOI

      10.1016/j.bbrc.2018.11.068

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] COP9 signalosome subunit 5 regulates cancer metastasis by deubiquitinating SNAIL.2018

    • Author(s)
      Watanabe K, Yokoyama S, Kaneto N, Hori T, Iwakami Y, Kato S, Hayakawa Y, Sakurai H, Fukuoka J, Saiki I.
    • Journal Title

      Oncotarget

      Volume: 9 Issue: 29 Pages: 20670-20680

    • DOI

      10.18632/oncotarget.25060

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 悪性黒色腫におけるSOX10を介したPD-L1の発現制御機構2020

    • Author(s)
      高橋篤司、横山悟、早川芳弘、櫻井宏明
    • Organizer
      第24回日本がん分子標的治療学会
    • Related Report
      2020 Annual Research Report
  • [Presentation] ストレス応答キナーゼp38によるRSK-EphA2経路の制御機構2020

    • Author(s)
      周越、横山悟、櫻井宏明
    • Organizer
      第24回日本がん分子標的治療学会
    • Related Report
      2020 Annual Research Report
  • [Presentation] 悪性黒色腫におけるSOX10を介したPD-L1発現制御機構2020

    • Author(s)
      高橋篤司、早川芳弘、櫻井宏明、横山悟
    • Organizer
      第19回次世代を担う若手のためのファーマ・バイオフォーラム2020
    • Related Report
      2020 Annual Research Report
  • [Presentation] PTEN 欠損によるがん遺伝子依存的な細胞運動亢進2020

    • Author(s)
      安田裕敬、早川芳弘、櫻井宏明、横山悟
    • Organizer
      第29回日本がん転移学会
    • Related Report
      2020 Annual Research Report
  • [Presentation] Non-canonical activation of EphA2 induces cell migration via Rab11 and Rab11-FIP1.2020

    • Author(s)
      周 越、山畑伊織、山村朋弘、横山 悟、櫻井宏明
    • Organizer
      第29回日本がん転移学会
    • Related Report
      2020 Annual Research Report
  • [Presentation] SrcによるTAB1リン酸化: 酸化ストレスの新しいシグナル経路2020

    • Author(s)
      岩原宏幸、岩田悠輔、名取香奈子、小澤龍彦、周越、定清直、横山悟、櫻井宏明
    • Organizer
      フォーラム2019 衛生薬学・環境トキシコロジー
    • Related Report
      2020 Annual Research Report
  • [Presentation] SOX10 negatively regulates PD-L1 expression in melanoma2020

    • Author(s)
      Satoru Yokoyama, Atsushi Takahashi, Yue Zhou, Yoshihiro Hayakawa, Hiroaki Sakurai
    • Organizer
      The 79th Annual meeting of the Japanese Cancer Association
    • Related Report
      2020 Annual Research Report
  • [Presentation] Acquired immune resistance mechanism of melanoma through GSTA4-dependent redox pathway2020

    • Author(s)
      Sisca Ucche, Satoru Yokoyama, Yoshihiro Hayakawa
    • Organizer
      The 79th Annual meeting of the Japanese Cancer Association
    • Related Report
      2020 Annual Research Report
  • [Presentation] Regulation of cancer cell malignancy via MK2-RSK-EphA2 axis.2020

    • Author(s)
      Yue Zhou, Ryota Oki, Iori Yamahata, Satoru Yokoyama, Sakurai Hiroaki
    • Organizer
      The 79th Annual meeting of the Japanese Cancer Association
    • Related Report
      2020 Annual Research Report
  • [Presentation] Regulation of cancer cell motility via p38-MK2-RSK-EphA2 axis.2020

    • Author(s)
      周 越、大木良太、田中章裕、山畑伊織、、横山 悟、櫻井宏明
    • Organizer
      第43回日本分子生物学会年会
    • Related Report
      2020 Annual Research Report
  • [Presentation] GIST細胞におけるRSK阻害剤BI-D1870のKIT発現抑制による細胞増殖抑制効果2019

    • Author(s)
      石田勝也,福司弥生,周 越,横山 悟,櫻井 宏明
    • Organizer
      第23回日本がん分子標的治療学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] CDK2/9阻害剤DinaciclibによるBAKを介した抗悪性黒色腫効果と新規併用療法の提案2019

    • Author(s)
      横山 悟,早川芳弘,櫻井宏明
    • Organizer
      第23回日本がん分子標的治療学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] STAMBPは、SLUGタンパク質の安定性を調節し、悪性黒色腫の転移を制御する2019

    • Author(s)
      横山悟,岩上雄亮,櫻井宏明,早川芳弘
    • Organizer
      第28回日本がん転移学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 白斑誘導物質ロドデノールによる抗悪性黒色腫効果の検討2019

    • Author(s)
      横山 悟,早川芳弘,櫻井宏明
    • Organizer
      フォーラム2019 衛生薬学・環境トキシコロジー
    • Related Report
      2019 Research-status Report
  • [Presentation] IMQ誘発乾癬モデルに対する桑白皮抽出エキスの有用性2019

    • Author(s)
      梅山 凜,横山 悟,早川芳弘
    • Organizer
      第36回和漢医薬学会総会
    • Related Report
      2019 Research-status Report
  • [Presentation] Anti-metastatic Activity of gugulipid extract by targeting cell intrinsic inflammatory pathways2019

    • Author(s)
      Abdellatef A, Shinguryo Y, Yokoyama S, Meselhy MR, Hayakawa Y
    • Organizer
      第36回和漢医薬学会総会
    • Related Report
      2019 Research-status Report
  • [Presentation] 非定型的活性型EphA2による細胞遊走促進は小胞遊走関連タンパクRab11に依存する2019

    • Author(s)
      周 越,山畑伊織,山村朋弘,横山 悟,櫻井宏明
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] Rational combination therapy for melanoma with CDK2/9 inhibition by targeting BAK-dependent cell death2019

    • Author(s)
      徐 小鴎,横山 悟,早川芳弘
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] Anti-inflammatory effect of Morus alba L. bark by suppressing NF-kB signaling pathway2019

    • Author(s)
      梅山 凜,横山 悟,早川芳弘
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] Anti-tumor effect of guggul extract by targeting breast cancer cell intrinsic inflammatory pathways2019

    • Author(s)
      Abdellatef A,横山 悟,早川芳弘
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Research-status Report
  • [Presentation] 消化管間質腫瘍細胞におけるRSK阻害剤BI-D1870のKIT発現抑制による細胞増殖抑制効果2019

    • Author(s)
      石田勝也,福司弥生,周 越,横山 悟,櫻井宏明
    • Organizer
      日本薬学会北陸支部第131回例会
    • Related Report
      2019 Research-status Report
  • [Presentation] 悪性黒色腫におけるSOX10を介したPD-L1の発現制御機構2019

    • Author(s)
      佐藤弘樹,高橋篤司,横山 悟,櫻井宏明
    • Organizer
      日本薬学会北陸支部第131回例会
    • Related Report
      2019 Research-status Report
  • [Presentation] RSK-EphA2経路によって誘導される細胞遊走はRab11とRab11-FIP1に依存する2019

    • Author(s)
      周 越,山畑伊織,山村朋弘,横山 悟,櫻井宏明
    • Organizer
      第42回日本分子生物学会
    • Related Report
      2019 Research-status Report
  • [Presentation] Anti-melanoma effect of CDK inhibitor and its combination strategy with BRAF inhibition2018

    • Author(s)
      Xu X, Yokoyama S, Hayakawa Y
    • Organizer
      The 77th Annual Meeting of the Japanese Cancer Association
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research
  • [Presentation] COPS5はSNAILの脱ユビキチン化を介して、がん転移を制御する2018

    • Author(s)
      横山悟、櫻井宏明、早川芳弘
    • Organizer
      第27回日本がん転移学会
    • Related Report
      2018 Research-status Report
  • [Remarks] 富山大学 学術研究部薬学・和漢系 がん細胞生物学研究室

    • URL

      http://www.pha.u-toyama.ac.jp/cliche2/index-j.html

    • Related Report
      2020 Annual Research Report 2019 Research-status Report
  • [Remarks] 富山大学・大学院医学薬学研究部(薬学)がん細胞生物学研究室

    • URL

      http://www.pha.u-toyama.ac.jp/cliche2/index-j.html

    • Related Report
      2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi